Related Experiment Videos
The effect of HIV coinfection on hepatitis C: A review
P J Gaglio1, A Akingbola, M Viacos
1Tulane University Medical School, New Orleans, Louisiana, USA.
Insights
Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) coinfection complicates patient outcomes. HIV therapy can worsen liver injury in coinfected patients, necessitating further research on combined treatment strategies.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) and Human Immunodeficiency Virus (HIV) coinfection is prevalent.
- Advances in HIV therapy have increased the lifespan of coinfected individuals, leading to more pronounced HCV-related pathology.
- Understanding the complex interplay between HCV and HIV is crucial for managing coinfected patients.
Observation:
- A case presentation of an HIV/HCV coinfected patient illustrates the clinical course.
- The review discusses the pathobiology and interrelation of HCV and HIV in coinfected individuals.
- The impact of treatment on this specific patient population is examined.
Findings:
- HIV infection adversely impacts the natural progression of HCV.
- HIV-directed therapy can potentially enhance immune responses, paradoxically exacerbating HCV-induced liver damage.
- The interaction between HIV and HCV is intricate and multifaceted.
Implications:
- Further research is essential to evaluate the effects of combined anti-HIV and anti-HCV therapies.
- Optimizing treatment strategies for HIV/HCV coinfected patients is critical for improving long-term outcomes.
- This review highlights the need for tailored management approaches in coinfected populations.
Abstract:
Many Hepatitis C (HCV) infected patients are coinfected with HIV. As HIV-directed anti-viral therapy has delayed HIV progression and mortality, pathologic consequences of HCV infection are occurring at an increased rate. In this review, a case presentation delineating the clinical course of an HIV/HCV coinfected patient at our institution is presented. The pathobiology, interrelation of HCV and HIV infection in coinfected patients is discussed as well as the effect of treatment in this unique patient population. The interaction of HIV and HCV coinfection is complex. It is clear that HIV infection negatively affects the natural history of HCV, while HIV-directed therapy may enhance immunologic response and exacerbate hepatocellular injury induced by HCV. Further studies assessing the effect of anti-HIV and anti-HCV-directed therapy on the clinical course of HCV/HIV coinfected patients is warranted.